Related Experiment Video
Updated: May 30, 2026
11:56
Derivation of Human Embryonic Stem Cells by Immunosurgery
Published on: December 13, 2007
Derivation of human parthenogenetic stem cell lines
Nikolay Turovets1, Andrey Semechkin, Leonid Kuzmichev
1International Stem Cell Corporation, Oceanside, CA, USA. nturovets@intlstemcell.com
Methods in Molecular Biology (Clifton, N.J.)
|August 9, 2011
Summary
Human parthenogenetic stem cells (hpSCs) derived from oocytes show pluripotency and differentiation capabilities. HLA-matched hpSCs offer immune compatibility for cell-based therapies, derived from unfertilized oocytes.
Area of Science:
- Reproductive biology
- Stem cell science
- Immunology
Background:
- Pluripotent stem cells (PSCs) are crucial for regenerative medicine.
- Human embryonic stem cells (hESCs) have therapeutic potential but face ethical and immunological challenges.
- Parthenogenetic activation of oocytes offers an alternative source of PSCs.
Purpose of the Study:
- To describe methods for deriving human parthenogenetic stem cell (hpSC) lines.
- To highlight the potential of hpSCs for cell-based transplantation therapy.
- To discuss the immunological advantages of hpSCs.
Main Methods:
- Parthenogenetic activation of human oocytes using different techniques.
- Cultivation of activated oocytes to the blastocyst stage.
- Derivation and characterization of hpSC lines.
Main Results:
- hpSCs exhibit characteristics of hESCs, including self-renewal and differentiation into all germ lineages.
- hpSC lines can be generated as either HLA heterozygous or HLA homozygous.
- HLA-matched hpSCs provide histocompatibility with the oocyte donor or population segments.
Conclusions:
- hpSCs are a promising alternative to hESCs for cell-based therapies.
- The derivation from unfertilized oocytes bypasses ethical concerns associated with embryonic stem cells.
- HLA matching in hpSCs reduces immune rejection, enhancing their therapeutic potential.
Related Concept Videos
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
00:58Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...